Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Erratum: Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target (Science Translational Medicine (2018) DOI: 10.1126/scitranslmed.aap9840)

  • D. Liu
  • , C. C. Wong
  • , L. Fu
  • , H. Chen
  • , L. Zhao
  • , C. Li
  • , Y. Zhou
  • , Y. Zhang
  • , W. Xu
  • , Y. Yang
  • , B. Wu
  • , G. Cheng
  • , P. B.S. Lai
  • , N. Wong
  • , J. J.Y. Sung
  • , J. Yu

Producción científica: Comment/debate

4 Citas (Scopus)

Resumen

In the Research Article "Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target," the missing accession number has been added to the Data and materials availability section of the article. The PDF and HTML (full text) have been corrected.

Idioma originalEnglish
Número de artículoeaav4522
PublicaciónScience Translational Medicine
Volumen10
N.º460
DOI
EstadoPublished - sept 26 2018

Nota bibliográfica

Publisher Copyright:
Copyright © 2018 The Authors.

ASJC Scopus subject areas

  • General Medicine

Huella

Profundice en los temas de investigación de 'Erratum: Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target (Science Translational Medicine (2018) DOI: 10.1126/scitranslmed.aap9840)'. En conjunto forman una huella única.

Citar esto